Tighe Reardon

Insider Reports History

Location
La Jolla, CA
Signature
/s/ Tighe Reardon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tighe Reardon:

Company Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Acting Chief Financial Officer Common Stock 3,340,018 $182,865,986 $54.75 03 Jun 2024 By Avalon BioVentures SPV I, L.P.
Janux Therapeutics, Inc. Acting Chief Financial Officer Common Stock 633,673 $34,693,597 $54.75 03 Jun 2024 By Avalon BioVentures I, LP
Janux Therapeutics, Inc. Acting Chief Financial Officer Common Stock 174,989 $9,580,648 $54.75 03 Jun 2024 Direct
Janux Therapeutics, Inc. Acting Chief Financial Officer Stock Option (right to buy) 157,000 02 Jan 2024 Direct

Insider Reports Filed by Tighe Reardon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 03 Jun 2024 2 -$45,043,975 4 Acting Chief Financial Officer 05 Jun 2024, 19:23
JANX Janux Therapeutics, Inc. 02 Jan 2024 1 $0 4 Acting Chief Financial Officer, 10%+ Owner 03 Jan 2024, 16:52
JANX Janux Therapeutics, Inc. 13 Nov 2023 1 +$4,988,643 4 Acting Chief Financial Officer, 10%+ Owner 15 Nov 2023, 16:48
JANX Janux Therapeutics, Inc. 03 Jan 2023 1 $0 4 Acting Chief Financial Officer, 10%+ Owner 05 Jan 2023, 15:34
JANX Janux Therapeutics, Inc. 03 Jan 2022 1 $0 4 Acting Chief Financial Officer, 10%+ Owner 05 Jan 2022, 16:27
JANX Janux Therapeutics, Inc. 15 Jun 2021 5 +$10,699,987 4 Acting Chief Financial Officer, 10%+ Owner 16 Jun 2021, 18:11
JANX Janux Therapeutics, Inc. 10 Jun 2021 0 $0 3 Acting Chief Financial Officer, 10%+ Owner 10 Jun 2021, 19:18